About the event:
In Innovayt’s presentation we will give an overview of the newest and most relevant soft funding programs currently available to biotech startups, and to SMEs in general, at the European level, while also touching upon the most obvious opportunities in Danish programs.
We will spend time discussing how to match a given bio-based concept with the various access criteria for soft funding programs, including the assessment of Technology Readiness Level (TRL), which has become a frequently used criterion in many programs, and often poses difficulties when applied in biomedicine and medtech contexts.
In addition, we will touch upon a few do’s and dont’s of SME proposal writing based on our experience. The goal of the session will be to give participants a grand overview of current opportunities, which will allow focus for their fundraising to follow.
Program:
- Funding opportunities in for biotech start-ups (general overview)
- Focus on new EU funding programs
- What happens after Horizon2020?
- Q&A
About the presenter:
Innovayt is an innovation consultancy. We specialise in helping companies obtain funding for their projects through the preparation high quality funding applications and business plans.
Innovayt’s mission is to help clients create value through innovation. We combine a solid business and technology foundation with superior knowledge of national and international funding instruments. This allows us to make a positive difference on projects – from ideation and concept to funding and implementation – and to ensure that our client’s ideas are implemented to their full potential.
